Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney Transplant.

Macedo C, Hadi K, Walters J, Elinoff B, Marrari M, Zeevi A, Ramaswami B, Chalasani G, Landsittel D, Shields A, Alloway R, Lakkis FG, Woodle ES, Metes D.

Kidney Int Rep. 2018 Dec 8;4(3):455-469. doi: 10.1016/j.ekir.2018.11.020. eCollection 2019 Mar.

2.

Antibody-Mediated Rejection of Solid-Organ Allografts.

Lakkis FG, Chalasani G, Hariharan S.

N Engl J Med. 2018 Dec 27;379(26):2580. doi: 10.1056/NEJMc1813976. No abstract available.

PMID:
30586533
3.

Phenotype, function, and differentiation potential of human monocyte subsets.

Boyette LB, Macedo C, Hadi K, Elinoff BD, Walters JT, Ramaswami B, Chalasani G, Taboas JM, Lakkis FG, Metes DM.

PLoS One. 2017 Apr 26;12(4):e0176460. doi: 10.1371/journal.pone.0176460. eCollection 2017.

4.

B Cells, Antibodies, and More.

Hoffman W, Lakkis FG, Chalasani G.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):137-54. doi: 10.2215/CJN.09430915. Epub 2015 Dec 23. Review.

5.

The end is in sight: targeting sensitization in hematopoietic cell transplantation.

Ramaswami B, Chalasani G.

Am J Transplant. 2015 Apr;15(4):857-8. doi: 10.1111/ajt.13127. Epub 2015 Mar 11. No abstract available.

6.

B cells mediate chronic allograft rejection independently of antibody production.

Zeng Q, Ng YH, Singh T, Jiang K, Sheriff KA, Ippolito R, Zahalka S, Li Q, Randhawa P, Hoffman RA, Ramaswami B, Lund FE, Chalasani G.

J Clin Invest. 2014 Mar;124(3):1052-6. doi: 10.1172/JCI70084. Epub 2014 Feb 10.

7.

Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.

Ezzelarab MB, Zahorchak AF, Lu L, Morelli AE, Chalasani G, Demetris AJ, Lakkis FG, Wijkstrom M, Murase N, Humar A, Shapiro R, Cooper DK, Thomson AW.

Am J Transplant. 2013 Aug;13(8):1989-2005. doi: 10.1111/ajt.12310. Epub 2013 Jun 11.

8.

Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells.

Zhang H, Stolz DB, Chalasani G, Thomson AW.

Clin Exp Immunol. 2013 Sep;173(3):473-9. doi: 10.1111/cei.12126.

9.

Exosomes released from Mycoplasma infected tumor cells activate inhibitory B cells.

Yang C, Chalasani G, Ng YH, Robbins PD.

PLoS One. 2012;7(4):e36138. doi: 10.1371/journal.pone.0036138. Epub 2012 Apr 27.

10.

Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation.

Macedo C, Walters JT, Orkis EA, Isse K, Elinoff BD, Fedorek SP, McMichael JM, Chalasani G, Randhawa P, Demetris AJ, Zeevi A, Tan H, Shapiro R, Landsittel D, Lakkis FG, Metes D.

Transplantation. 2012 Apr 27;93(8):813-21. doi: 10.1097/TP.0b013e318247a717.

11.

Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology.

Zecher D, Li Q, Williams AL, Walters JT, Baddoura FK, Chalasani G, Rothstein DM, Shlomchik WD, Demetris AJ, Lakkis FG.

Transpl Immunol. 2012 Mar;26(2-3):113-8. doi: 10.1016/j.trim.2011.12.006. Epub 2011 Dec 24.

12.

Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, Chalasani G, Sayegh MH, Najafian N, Rothstein DM.

J Clin Invest. 2011 Sep;121(9):3645-56. doi: 10.1172/JCI46274. Epub 2011 Aug 8.

13.

The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response.

Ramaswami B, Popescu I, Macedo C, Luo C, Shapiro R, Metes D, Chalasani G, Randhawa PS.

Clin Vaccine Immunol. 2011 May;18(5):815-24. doi: 10.1128/CVI.00487-10. Epub 2011 Mar 2.

14.

B cells help alloreactive T cells differentiate into memory T cells.

Ng YH, Oberbarnscheidt MH, Chandramoorthy HC, Hoffman R, Chalasani G.

Am J Transplant. 2010 Sep;10(9):1970-80. doi: 10.1111/j.1600-6143.2010.03223.x.

15.

The yin and yang of B cells in graft rejection and tolerance.

Zarkhin V, Chalasani G, Sarwal MM.

Transplant Rev (Orlando). 2010 Apr;24(2):67-78. doi: 10.1016/j.trre.2010.01.004. Epub 2010 Feb 10. Review.

PMID:
20149626
16.

Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8+ memory T cells.

Oberbarnscheidt MH, Obhrai JS, Williams AL, Rothstein DM, Shlomchik WD, Chalasani G, Lakkis FG.

Am J Transplant. 2010 Jan;10(1):162-7. doi: 10.1111/j.1600-6143.2009.02871.x. Epub 2009 Nov 24.

17.

Role of secondary lymphoid tissues in primary and memory T-cell responses to a transplanted organ.

Ng YH, Chalasani G.

Transplant Rev (Orlando). 2010 Jan;24(1):32-41. doi: 10.1016/j.trre.2009.09.003. Epub 2009 Oct 20. Review.

18.

Deposition of complement product C4d in anti-glomerular basement membrane glomerulonephritis.

Batal I, Chalasani G, Wu C, Shapiro R, Bastacky S, Randhawa P.

Am J Kidney Dis. 2009 Jun;53(6):1098-101. doi: 10.1053/j.ajkd.2008.10.008. Epub 2008 Dec 11. No abstract available.

PMID:
19084308
19.

The roles of CD8 central and effector memory T-cell subsets in allograft rejection.

Oberbarnscheidt MH, Ng YH, Chalasani G.

Am J Transplant. 2008 Sep;8(9):1809-18. doi: 10.1111/j.1600-6143.2008.02335.x. Epub 2008 Jul 28.

20.

Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs.

Obhrai JS, Oberbarnscheidt MH, Hand TW, Diggs L, Chalasani G, Lakkis FG.

J Immunol. 2006 Apr 1;176(7):4051-8.

Supplemental Content

Loading ...
Support Center